Japanese Researchers Confirm the Value of CT Index for Mesothelioma Diagnosis, According to Surviving Mesothelioma

Share Article

Their new study highlights the differences between CT images of peritoneal mesothelioma and those of other types of cancers.

CT Scans Help Differentiate Mesothelioma

CT Index for Accurate Mesothelioma Diagnosis

Among malignant peritoneal mesothelioma cases, the incidences of multiple tumor masses, intestinal wall thickening and pleural plaque were significantly higher...

Scientists in Japan have released new findings illustrating how CT imaging can help in the differential diagnosis of malignant peritoneal mesothelioma, a deadly abdominal cancer linked to asbestos. Surviving Mesothelioma has just posted details of the research in a new article. Click here to read it now.

Physicians, pathologists and a radiologist at Okayama University Hospital examined the CT images of 43 patients who had died of peritoneal mesothelioma and compared them with the images of those who had died of other cancers.

“Among malignant peritoneal mesothelioma cases, the incidences of multiple tumor masses, intestinal wall thickening and pleural plaque were significantly higher than non-MPM cases,” writes radiologist Dr. K. Kato, lead author on the report.

The team found that all of the mesothelioma cases scored a four or higher on the MPM-CT Index, making it a potentially useful way to help diagnosis the disease.

“Mesothelioma diagnosis is always a challenge, but it is critical step to maximize the odds of survival,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “If the MPM-CT Index makes diagnosis easier and more accurate, it could be a lifesaver for mesothelioma patients around the world.”

Details of the Japanese stud, the peritoneal mesothelioma CT Index, and how it could apply to patients and families, see Mesothelioma Diagnosis: CT Index May Make it Easier, now available on the Surviving Mesothelioma website.

Kato, K, et al, “Computed Tomographic Features of Malignant Peritoneal Mesothelioma”, March 2016, Anticancer Research, pp. 1067-72, https://www.ncbi.nlm.nih.gov/pubmed/26976999

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website